| Role of the tissue factor pathway in synovial inflammation. | |
| | |
MedLine Citation:
|
PMID: 12632417 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Clinical and experimental evidence suggests that extravascular fibrin deposition in arthritic joints is prominent and deleterious. The aim of this study was to investigate the contributions of tissue factor (TF) and its inhibitor, TF pathway inhibitor (TFPI), in arthritis. METHODS: Synovial tissue specimens obtained from 10 patients with rheumatoid arthritis (RA) and 12 patients with osteoarthritis (OA) were scored histologically for inflammation and fibrin content. TF and TFPI levels were assayed at antigenic and functional levels. TF messenger RNA (mRNA) levels were determined using RNase protection assays. The effect of TF inhibition in murine antigen-induced arthritis (AIA) was assessed by administering systemically active site-blocked activated factor VIIa (FVIIai). RESULTS: Functional TF activity was significantly increased in synovial membranes from RA patients compared with those from OA patients. In contrast, no difference in TF mRNA and TF antigenic levels was observed between these 2 groups. This discrepancy can be accounted for by TFPI, because we observed a negative correlation between TF activity and TFPI activity. There was a significant difference between the RA and OA groups in terms of synovial inflammation, with more inflammation observed in the RA group. Most importantly, TF activity was associated with fibrin (P = 0.024) and with histologic inflammation (P = 0.03) scores. In AIA, inhibition of TF-induced coagulation by FVIIai led, on day 9 of arthritis, to decreased synovial thickness and decreased articular cartilage damage, although only the latter difference between controls and treated mice reached significance (P < 0.04). Finally, in FVIIai-treated mice, there was a strong negative association between the prothrombin time and intraarticular fibrin deposition. CONCLUSION: Our results show that TF expression in arthritic synovial tissue favors extravascular coagulation and may play a role in inflammation in RA. In this context, TF inhibitors may be of therapeutic value. |
| | |
Authors:
|
Nathalie Busso; Carole Morard; Roberto Salvi; Veronique Péclat; Alexander So |
Related Documents
:
|
12794787 - Bacterial components in the synovial tissue of patients with advanced rheumatoid arthri... 10857797 - Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis: an e... 9546487 - Early detection of vasospasm after acute subarachnoid hemorrhage using continuous eeg i... 20360897 - Intima-media thickness evolution after treatment with infliximab in patients with rheum... 21525737 - Abnormal cervical cytology in the diagnosis of uterine papillary serous carcinoma: earl... 508597 - Levamisole therapy for multiple warts. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Arthritis and rheumatism Volume: 48 ISSN: 0004-3591 ISO Abbreviation: Arthritis Rheum. Publication Date: 2003 Mar |
Date Detail:
|
Created Date: 2003-03-12 Completed Date: 2003-03-25 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0370605 Medline TA: Arthritis Rheum Country: United States |
Other Details:
|
Languages: eng Pagination: 651-9 Citation Subset: AIM; IM |
Affiliation:
|
Laboratoire de Rhumatologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. Nathalie.Busso@chuv.hospvd.ch |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Animals Arthritis, Experimental / prevention & control Arthritis, Rheumatoid / metabolism*, pathology Dansyl Compounds / therapeutic use Disease Models, Animal Factor VIIa / therapeutic use Female Fibrin / metabolism Fibrinolytic Agents / metabolism*, pharmacology Hindlimb / metabolism, pathology, radionuclide imaging Humans Immunohistochemistry Lipoproteins / genetics, metabolism*, pharmacology Male Mice Mice, Inbred C57BL Middle Aged Osteoarthritis / metabolism*, pathology RNA, Messenger / metabolism Synovitis / metabolism*, pathology Thromboplastin / genetics, metabolism* |
| Chemical | |
Reg. No./Substance:
|
0/Dansyl Compounds; 0/Fibrinolytic Agents; 0/Lipoproteins; 0/RNA, Messenger; 0/dansyl-glutamyl-glycyl-arginyl-factor VIIa; 0/lipoprotein-associated coagulation inhibitor; 9001-31-4/Fibrin; 9035-58-9/Thromboplastin; EC 3.4.21.21/Factor VIIa |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-lik...
Next Document: Expression of pleiotrophin, an embryonic growth and differentiation factor, in rheumatoid arthritis.